WADA 2026 Report: Doping Testing Up 9,100 Samples but Growth Decelerates Nearly Fourfold

In the summer of 2026, as the waters at national swimming meets fell quiet, a raw statistical table landed in my inbox. The World Anti-Doping Agency, known as WADA, published its total number of samples for the year: 297,965. That was 9,100 more than the previous year. The whole number sounds substantial, and it was enough for a press release to turn it into a headline about expanded testing.

But those of us who read data for a living do not stop at the whole number. We read the decimal, the rate of change of the rate of change, and the deviation between years. This year's decimal tells a very different story from the headline.

Testing-volume growth was 12.5% for 2026-2026. For 2026-2026, that figure dropped to 3.2%. The adverse analytical finding rate, what the field calls AAF, has barely moved for three years: 0.77% in 2026, 0.80% in 2026, and 0.78% in 2026. The system added nearly nine thousand samples, yet the detection rate stayed inside a 0.03 percentage-point band.

Numbers never lie, but they know how to hide. In a document with more than forty information points, the most carefully hidden part is not at the top. It sits in the middle, in the budget section, and in a single line about non-conformities in sample collection.

The foundation of a system

WADA coordinates global anti-doping rules, sitting above international sports federations and national anti-doping organizations. For swimming, this chain has three tiers. WADA sets the standards. World Aquatics, the international swimming governing body, applies those standards to its events. National anti-doping organizations enforce at the athlete level. A Vietnamese swimmer competing at the SEA Games is monitored by all three tiers at once, even if he may not know which tier is collecting his sample.

WADA's annual report does not tell the story of a specific athlete. It contains no names, no lanes, no records. It inspects the foundation: money in and out, the number of compliance audits, the number of samples, the number of investigations, and the status of a newly adopted code.

I read this kind of document with the same habit I developed in 2026, when I built my own xG table for the first twelve rounds of the V-League in Excel. That habit has two steps. First, separate the whole number from the decimal, because the decimal usually carries the signal. Second, separate the number from the label attached to it, because the label is usually chosen for effect.

COVID closed the stadiums, so I reopened the V-League directory. No league is meaningless. The same principle applies to a global governance report. No table of numbers is meaningless, including tables about budgets and audits, as long as the reader is willing to place them side by side.

This year, the testing data series is presented continuously from 2026 to 2026. That is valuable. A seven-year series lets a reader distinguish a single fluctuation from a genuine trend. For those who follow swimming in Vietnam and Southeast Asia, this series is the foundation beneath the medal, while the SEA Games and Olympic quotas are only the facade.

The whole number and the decimal

Testing volume rose from 288,865 samples in 2026 to 297,965 in 2026. The absolute increase was 9,100 samples, or 3.2%. A year earlier, the increase was 12.5%. If you only read the headline about strengthened sampling, you picture a steadily rising curve. The data show the opposite: growth has decelerated nearly fourfold.

This is not a trivial detail. In time-series analysis, the rate of change of the rate of change often matters more than the figure itself. A system that grows 12.5% then 3.2% is approaching saturation. If this curve continues, the next report may show growth under one percent, or flat.

There is an optimistic reading of this trend. Once a system reaches high coverage, adding more samples becomes harder and less valuable. From that angle, decelerating growth is a sign of maturity, not weakness. But to conclude that, you need one more data point: whether coverage is genuinely high, and whether it is evenly distributed across countries. The report does not answer that at the per-sport level, and I flag this as insufficient information.

For swimming, coverage is a more sensitive variable than for most sports. A sport with many events, athletes across levels from youth to professional, and high demand for out-of-competition testing will consume more testing resources. When global volume plateaus, smaller swimming federations tend to be hit first, because they have less voice in resource allocation.

The flat line called AAF

The AAF rate paints a different picture. Three years, three figures: 0.77%, 0.80%, 0.78%. Maximum deviation of 0.03 percentage points. For an anomaly hunter, the question is always: is this signal or noise? The answer lies in series length and sample breadth. With nearly three hundred thousand samples a year, a 0.03-point deviation is too small to call a genuine shift. This is a flat line.

A flat line in the detection rate, sitting beside a saturating volume curve. Placed together, these two facts produce three readings, and I want the reader to see all three before I choose one.

The first reading: the actual doping rate among athletes is stable, and the system reflects that reality. This is the most comfortable reading, but also the hardest to verify, because it assumes the system measures the underlying truth.

The second reading: the system is sampling more but into low-risk groups, keeping the overall rate unchanged even as coverage rises. This reading fits the decelerating volume, since expanding into low-risk groups tends to yield less detection value.

The third reading: the system is shifting from mass testing to targeted investigation, and the sample mix changes accordingly. This reading fits another part of the report, which I address next.

The report does not say which reading is correct. But the document's structure leans toward the third. And that is why I apply the word luck to none of the figures above.

Luck is something I do not have. I have probability and data thick enough to stand on.

The investigative pivot

WADA recorded more than 250 investigation operations, 88 laboratories dismantled, and more than 90 tons of substances seized during the reporting period. These are the figures of an activity direction quite different from urine and blood testing. Investigation is intelligence work: tracking networks, following money, coordinating with law enforcement. It does not produce pretty sample counts, but it can produce greater results per dollar spent.

The document describes this shift with a phrase I read again and again: from predominantly traditional testing to investigation and prevention. Having worked as a transfer-market administrator, I recognize this kind of pivot. People look at the valuation table, I look at the curve. Many deals die before they are announced, and many organizations change strategy before they change their official name.

WADA is doing exactly that. It is moving from measuring effort to measuring outcomes. A sample is a unit of effort. A dismantled network is a unit of outcome. In any monitoring system with finite resources, this is theoretically a sound move.

But theory and execution do not always align. Investigations generate outcomes that are easier to count and easier to publicize than routine testing. A laboratory raid is a headline. A negative urine sample is not. When an organization faces financial pressure, the publicity incentive can push it to prioritize flashy investigations over maintaining steady testing coverage. This is a structural risk, not a moral one.

The gap behind the balance sheet

The budget section holds the document's clearest weakness. WADA's budget came in 8.3 million USD below plan. Two major contributions were outstanding. The United States was short 3.8 million USD. Russia was short 3.9 million USD. Together, nearly 7.7 million USD, most of the budget gap.

This is where I weigh carefully before concluding, because I do not want to turn a correlation into a causation. The decelerating testing volume could simply be natural saturation. It could also be an early sign of resource pressure. These two data clusters sit pages apart, but they tell the same story when placed together. I flag this as a medium-confidence inference, not a firm conclusion.

The financial picture also has a counter-current. WADA recorded a net surplus of 1.2 million USD. A surplus and a budget shortfall coexisting sounds contradictory, but it is not. A net surplus often comes from cutting spending or deferring outlays. An organization that records a surplus while falling short of plan is usually controlling costs more tightly than necessary. And the cut, in a monitoring system, may be exactly the investment in testing capacity.

This is the kind of accounting paradox I often see in the transfer market. A club can report a net profit while gradually selling assets to balance the books. The financial statement looks clean, but squad quality declines. For WADA, the similar question is: was the 1.2 million USD surplus created by deferring investment in urine and blood sampling? The report does not answer directly, but the plateauing volume curve is a signal worth tracking.

For swimming, this is the most sensitive point in the whole analysis. Swimming is a resource-intensive testing sport: many events, many athletes at many levels, and high demand for out-of-competition checks. When budgets tighten, smaller swimming federations, including Vietnam and several Southeast Asian nations, may be hit first. Not because they are targeted, but because they sit at the end of the resource-allocation chain.

The buried signal in the audit section

The compliance audit section contains the most concrete figure on a worsening problem. The average number of non-conformities fell from 25.5 to 20 across nine audits. That sounds like progress. But broken down by category, non-conformities in the testing domain rose 11%. That group accounted for 45% of all findings, with 23% rated critical.

This is what I call a buried signal. The overall picture improves, the detail picture worsens. An organization looking at the average would celebrate. A careful reader sees the problem sitting exactly at the most important stage: sample collection.

I must be clear about the limits of this evidence. Nine audits is a small sample. At this sample size, the improvement from 25.5 to 20 may not represent the whole system. I will not build a forecasting model on nine data points, because doing so turns noise into signal, exactly the trap an anomaly hunter is most prone to. But the percentage rise in the testing category is a figure I will track next cycle, because it points in a clear direction.

Notably, testing non-conformities may cluster in low-resource countries. I do not have data to prove this, so I flag it as low-confidence inference. But if true, it creates an uncomfortable loop: a country with weak resources tests samples poorly, is rated non-compliant, and then finds it even harder to access resources to fix the problem.

A team does not collapse in one night. It collapses when its metrics stop connecting to one another. For an anti-doping system, the same holds: the system does not collapse in one report. It weakens when the financial metric, the volume metric, and the compliance metric begin to drift apart.

The athlete voice

The report also notes an athlete consultation mechanism with more than 600 athletes and commissions, spanning over 60 countries and more than 70 sports. This is a legitimacy-building effort, and in scale it is notable.

But the document does not say whether that input changed the substance of the code. The number of participants does not equal the weight of their input. As a long-distance swimmer, I am used to distinguishing distance swum from efficiency swum. An athlete can swim two thousand meters and make little progress if rhythm and technique do not align. Here too. You can count how many athletes took part, but not measure their influence on the final text.

For swimming, this consultation mechanism has an indirect significance. If athlete commissions grow stronger, procedural protections for athletes in doping cases may improve over time. This is a positive signal, but I flag it as low confidence because it lies outside the report's data scope.

The 2027 milestone

The 2027 edition of the World Anti-Doping Code was adopted in Busan, South Korea, and will take effect on January 1, 2027. This is a milestone with a specific date, and therefore the highest planning-value anchor in the entire report.

The period from now to that date is a compliance gap window. Organizations can continue behaving under the old rules while waiting for the new ones. In institutional economics, this is an incentive-discontinuity period: the cost of waiting is lower than the cost of early transition. I expect some organizations to delay adjustment until close to 2027, and for them, the preparation window will be very narrow.

This is why the 2027 milestone matters more than the report's headline suggests. A new code is only as strong as the readiness of the organizations that must enforce it. For Vietnamese swimming, the question is not when the code takes effect, but whether the national anti-doping organization has enough resources to transition before the deadline.

The contrarian angle

The press release headline says WADA expanded sample testing. The data show growth decelerated nearly fourfold and the detection rate stood still for three years. The gap between headline and data is the first thing I want to make clear, because it changes how the whole report should be read.

There is a common misreading of a stable AAF rate. Many readers see 0.78% and conclude the doping problem is under control. But a stable detection rate does not measure the level of doping in sport. It measures the ratio of positive samples to total samples, where both numerator and denominator are decided by the system. If the system shifts to targeted testing, the rate can hold steady or rise slightly even as coverage falls in certain groups. This is the fundamental error of reading a rate without reading its structure.

The second counterintuitive point lies in the relationship between quantity and effectiveness. With more than 250 investigation operations, 88 dismantled laboratories, and over 90 tons seized, WADA may be shifting from measuring effort to measuring outcomes. In principle, that is the right move. But a trap comes with it. Investigations produce outcomes that are easier to count and publicize than routine testing. If the organization is under financial pressure, it may prioritize flashy investigations over steady testing coverage.

For swimming, the risk sits here. The 8.3 million USD shortfall and the nearly 7.7 million USD owed by two countries are not merely an accounting story. They are a story about who pays to guarantee a clean lane. When the largest contributor and one of the most heavily tested nations both fall behind, the system must choose between expanding coverage and intensifying investigation. Neither choice is free.

The anchor ahead

WADA's next report will answer one specific question. Will testing-volume growth continue to decelerate, go flat, or turn negative? If the figure goes flat or falls while the funding gap remains unfilled, we will have evidence that resource pressure is eating into testing capacity, not just natural saturation.

In parallel, I am tracking the testing non-conformity share. If it passes 45% in the next audit cycle, the problem is no longer a few isolated organizations. It becomes a system problem, and a system cannot be fixed with a press release.

And the January 1, 2027 milestone still stands there, fixed. It is the only anchor in the entire report with a clear date, and therefore the thing worth scheduling tracking around. For Vietnamese swimming, the question is not when the code takes effect, but whether the national anti-doping organization has enough resources to transition before the deadline. That is the question I will return to when the next report is published.